Strong Tower Advisory Services Raises Stake in Solventum Corporation $SOLV

Key Points

• Strong Tower Advisory Services increased its stake in Solventum Corporation by 6.5% in Q2, holding 82,318 shares valued at approximately $6.24 million.
• Solventum reported a Q2 EPS of $1.69, exceeding analysts' expectations of $1.45, and indicated a revenue increase of 3.8% year-over-year to $2.16 billion.
• The company has a market capitalization of $12.23 billion and recently set its FY 2025 EPS guidance in the range of 5.800-5.950.

Strong Tower Advisory Services boosted its holdings in shares of Solventum Corporation (NYSE:SOLV - Free Report) by 6.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 82,318 shares of the company's stock after acquiring an additional 5,046 shares during the period. Solventum accounts for about 1.2% of Strong Tower Advisory Services' investment portfolio, making the stock its 27th largest holding. Strong Tower Advisory Services' holdings in Solventum were worth $6,243,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Rossby Financial LCC purchased a new position in Solventum during the 1st quarter valued at about $25,000. Strengthening Families & Communities LLC lifted its position in Solventum by 376.8% during the 1st quarter. Strengthening Families & Communities LLC now owns 329 shares of the company's stock valued at $25,000 after acquiring an additional 260 shares during the period. Barrett & Company Inc. lifted its position in Solventum by 206.2% during the 2nd quarter. Barrett & Company Inc. now owns 398 shares of the company's stock valued at $30,000 after acquiring an additional 268 shares during the period. Hara Capital LLC purchased a new position in Solventum during the 1st quarter valued at about $38,000. Finally, Smartleaf Asset Management LLC lifted its position in Solventum by 193.4% during the 1st quarter. Smartleaf Asset Management LLC now owns 534 shares of the company's stock valued at $40,000 after acquiring an additional 352 shares during the period.

Solventum Stock Performance

Shares of SOLV stock opened at $70.53 on Friday. The company has a 50 day moving average price of $72.75 and a 200-day moving average price of $72.11. Solventum Corporation has a 52 week low of $60.70 and a 52 week high of $85.92. The firm has a market capitalization of $12.23 billion, a PE ratio of 32.65, a P/E/G ratio of 2.92 and a beta of 0.50. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.14.

Solventum (NYSE:SOLV - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $1.69 EPS for the quarter, topping analysts' consensus estimates of $1.45 by $0.24. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The firm had revenue of $2.16 billion during the quarter, compared to analyst estimates of $2.12 billion. During the same period in the previous year, the business posted $1.56 earnings per share. The business's revenue for the quarter was up 3.8% on a year-over-year basis. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. As a group, equities research analysts expect that Solventum Corporation will post 6.58 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Weiss Ratings reissued a "hold (c-)" rating on shares of Solventum in a research report on Wednesday. Jefferies Financial Group assumed coverage on shares of Solventum in a report on Thursday, September 11th. They issued a "hold" rating and a $80.00 target price for the company. UBS Group assumed coverage on shares of Solventum in a report on Wednesday, October 1st. They issued a "neutral" rating and a $77.00 target price for the company. Wall Street Zen cut shares of Solventum from a "strong-buy" rating to a "buy" rating in a report on Tuesday, September 9th. Finally, Argus raised shares of Solventum from a "hold" rating to a "buy" rating and set a $90.00 target price for the company in a report on Tuesday, July 1st. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Solventum presently has a consensus rating of "Hold" and an average target price of $84.89.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Corporation (NYSE:SOLV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.